PH31417A - Nicotinic acid esters. - Google Patents

Nicotinic acid esters.

Info

Publication number
PH31417A
PH31417A PH4640898A PH4640898A PH31417A PH 31417 A PH31417 A PH 31417A PH 4640898 A PH4640898 A PH 4640898A PH 4640898 A PH4640898 A PH 4640898A PH 31417 A PH31417 A PH 31417A
Authority
PH
Philippines
Prior art keywords
saturated
carbon atoms
acid esters
nicotinic acid
compounds
Prior art date
Application number
PH4640898A
Other languages
English (en)
Inventor
Bjork Anders
Andersson Gunnar
Ludwig Catarina
Seifert Elisabeth
Nilsson Arne
Lundstedt Torbjorn
Abramo Lisbeth
Pettersson Goran
Nordvi Curt
Wu Jin Chang
Original Assignee
Itabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itabi Pharmacia Ab filed Critical Itabi Pharmacia Ab
Publication of PH31417A publication Critical patent/PH31417A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH4640898A 1992-06-25 1998-06-24 Nicotinic acid esters. PH31417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters

Publications (1)

Publication Number Publication Date
PH31417A true PH31417A (en) 1998-10-29

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
PH4640898A PH31417A (en) 1992-06-25 1998-06-24 Nicotinic acid esters.

Country Status (27)

Country Link
US (1) US5658910A (ja)
EP (2) EP1120410B1 (ja)
JP (1) JP3306827B2 (ja)
KR (1) KR100302216B1 (ja)
CN (1) CN1085981C (ja)
AT (2) ATE209634T1 (ja)
AU (1) AU681346B2 (ja)
BG (1) BG62000B1 (ja)
CA (1) CA2139112C (ja)
CZ (1) CZ281975B6 (ja)
DE (2) DE69333655D1 (ja)
DK (1) DK0673368T3 (ja)
EE (1) EE03122B1 (ja)
ES (1) ES2169044T3 (ja)
FI (1) FI107151B (ja)
HU (2) HU220613B1 (ja)
IL (1) IL106135A (ja)
NO (1) NO302945B1 (ja)
NZ (1) NZ253823A (ja)
PH (1) PH31417A (ja)
PT (1) PT673368E (ja)
RO (1) RO115725B1 (ja)
RU (1) RU2127732C1 (ja)
SE (1) SE9201956D0 (ja)
SK (1) SK279393B6 (ja)
WO (1) WO1994000434A1 (ja)
ZA (1) ZA934596B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
PE20211496A1 (es) * 2018-05-09 2021-08-11 Lg Chemical Ltd Nuevo compuesto que presenta actividad inhibidora de enteropeptidasa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
HU9403786D0 (en) 1995-02-28
NO945022D0 (no) 1994-12-23
CN1086811A (zh) 1994-05-18
NO945022L (no) 1995-02-13
DE69331234D1 (de) 2002-01-10
CZ281975B6 (cs) 1997-04-16
EP0673368B1 (en) 2001-11-28
SK158594A3 (en) 1995-07-11
JP3306827B2 (ja) 2002-07-24
CA2139112A1 (en) 1994-01-06
ATE278671T1 (de) 2004-10-15
ES2169044T3 (es) 2002-07-01
CA2139112C (en) 2006-03-21
ATE209634T1 (de) 2001-12-15
EP1120410A1 (en) 2001-08-01
DK0673368T3 (da) 2002-03-18
WO1994000434A1 (en) 1994-01-06
CZ327494A3 (en) 1995-09-13
PT673368E (pt) 2002-05-31
HU220613B1 (hu) 2002-03-28
BG99289A (bg) 1995-09-29
RU2127732C1 (ru) 1999-03-20
DE69333655D1 (de) 2004-11-11
AU681346B2 (en) 1997-08-28
FI107151B (fi) 2001-06-15
IL106135A0 (en) 1993-10-20
CN1085981C (zh) 2002-06-05
RO115725B1 (ro) 2000-05-30
BG62000B1 (bg) 1998-12-30
EP1120410B1 (en) 2004-10-06
EP0673368A1 (en) 1995-09-27
KR950702186A (ko) 1995-06-19
ZA934596B (en) 1994-02-14
KR100302216B1 (ko) 2001-11-22
JPH07508517A (ja) 1995-09-21
FI946085A (fi) 1994-12-23
SK279393B6 (sk) 1998-11-04
DE69331234T2 (de) 2002-08-08
RU94046310A (ru) 1996-10-27
HUT71406A (en) 1995-11-28
IL106135A (en) 1999-01-26
FI946085A0 (fi) 1994-12-23
EE03122B1 (et) 1998-10-15
NZ253823A (en) 1996-01-26
HU210875A9 (en) 1995-08-28
NO302945B1 (no) 1998-05-11
AU4519393A (en) 1994-01-24
SE9201956D0 (sv) 1992-06-25
US5658910A (en) 1997-08-19

Similar Documents

Publication Publication Date Title
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
ATE136882T1 (de) Carbamidsäureester-derivate, mittel und herstellungsverfahren
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
FI931765A (fi) Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar
PH31417A (en) Nicotinic acid esters.
IE893211L (en) Benzoxazepinone Process
DE3564263D1 (en) Process for preparing azetidine derivatives and intermediates therein
ES8301963A1 (es) Un procedimiento para preparacion de nuevas piperidinoquinazolinas.
DE68908761D1 (de) Monopersulfate von stickstoffenthaltenden heterocyclischen Polypercarbonsäuren.
DE3662039D1 (de) Novel diamine derivatives
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder
DE69333903D1 (de) Optisch aktive 1-Phenylpyrrolidonderivate
GEP19981536B (en) Process for the Preparation of 1-Ethyl-1(Hydroxymethyl)-1,2,3,4,6,7,12,12-Octahydro-Indolo [2,3-) Quinolizine and Novel Intermediates ^